QLT Will Purchase Drug Delivery Firm | Chemical & Engineering News
Volume 85 Issue 42 | p. 21 | Concentrates
Issue Date: October 15, 2007

QLT Will Purchase Drug Delivery Firm

Department: Business

QLT will acquire ForSight Newco, owner of an ocular drug delivery system, for $42 million plus possible future milestone payments. ForSight Newco, a spin-off of ForSight Labs, has developed a sustained- release plug that can replace eye drops for treating glaucoma and other eye ailments. Sales of QLT's main product, Visudyne for age-related macular degeneration, are declining in the face of competition from Genentech's Lucentis.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment